<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04433117</url>
  </required_header>
  <id_info>
    <org_study_id>58349</org_study_id>
    <nct_id>NCT04433117</nct_id>
  </id_info>
  <brief_title>Bone Material Comparison in Maxillary Sinus Augmentation</brief_title>
  <official_title>Bone Quality and Quantity in the Maxillary Sinus Grafted With Xenograft or Synthetic Bone Substitute: A Radiographic and Histomorphometric Randomized Controlled Clinical Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rachad Kudsi</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Kentucky</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hard and soft tissue deficiencies of an alveolar ridge arise as sequelae of tooth extraction&#xD;
      when socket preservation is not applied. In addition, extraction of posterior maxillary teeth&#xD;
      causes pneumatization of the maxillary sinus in relation to other fixed landmarks such as the&#xD;
      teeth. These anatomic sinus limitations and alveolar bone deficiencies are the main&#xD;
      challenges for dental implant placement. Different bone substitutes have been used to augment&#xD;
      bone in pneumatized maxillary sinuses.&#xD;
&#xD;
      Scaffolding materials such as xenografts or synthetics substitutes have been proven to be a&#xD;
      viable alternative.&#xD;
&#xD;
      Xenografts are obtained from nonhuman species and serve as a scaffold for the formation of&#xD;
      new bone (osteoconduction). Histologic evaluation of maxillary sinuses grafted with&#xD;
      xenografts revealed newly formed bone to be mostly woven bone with some remodeling to&#xD;
      lamellar bone. These histologic findings reaffirm the osteoconductive ability of xenografts&#xD;
      when used as the sole grafting material in maxillary sinus augmentation. Xenografts appear to&#xD;
      be an effective method for maxillary sinus grafting and demonstrate limited resorption over&#xD;
      time. Sinuses augmented with synthetic bone substitute (SBS) also appear to successfully&#xD;
      integrate based on recent histomorphometric studies. Vascularization and trabecular bone&#xD;
      formation in sinuses grafted with SBS has been previously demonstrated. One type of SBS&#xD;
      includes porous granules of bioactive and resorbable silica-calcium phosphate nanocomposite&#xD;
      (ShefaBone). ShefaBone grafts offer a novel alternative that can potentially unite the 3&#xD;
      salient bone-forming properties (osteoinduction, osteoconduction, and osteogenesis).&#xD;
      ShefaBone has unique properties including: 1) bioactivity 2) bioresorbablility, and 3)&#xD;
      allowing for the uptake of calcium ions from the physiological solution and releasing&#xD;
      phosphate and silicate ions which aid in bone formation. A material with such properties will&#xD;
      substitute bone in a more controlled and effective combination that can be obtained in many&#xD;
      clinical situations, without the disadvantages found with autograft. ShefaBone has&#xD;
      demonstrated successful regenerative properties for bony defects. To our knowledge, there is&#xD;
      no reported clinical studies on the use of SCPC material to graft a pneumatized maxillary&#xD;
      sinus. This aim of this current study is to compare SCPC to commonly used xenograft material&#xD;
      in an augmented maxillary sinus.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. To assess the quality and quantity of the maxillary sinus bone prior to the placement of&#xD;
           dental implants and subsequent restorations, approximately 20 patients will be randomly&#xD;
           assigned to receive an augmentation of the maxillary sinus region using either Shefabone&#xD;
           (synthetic bone) or Bio-Oss (xenograft).&#xD;
&#xD;
        2. With the use of pre-operative and post-operative limited view CBCT radiography, the&#xD;
           maxillary sinus bone density will be assessed and compared between the individuals&#xD;
           receiving Shefabone and the individuals receiving xenograft material.&#xD;
&#xD;
        3. Histomorphometric analysis will be used to assess, compare and contrast the quality and&#xD;
           the quantity of the new vital bone cells generated when using these different graft&#xD;
           materials.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 17, 2020</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">June 2022</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized controlled clinical trial. Entails 2 groups of subjects which will be randomly assigned. Group 1 will be the control group, and group 2 is test group.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Bone Density - Limited View CBCT Measurements</measure>
    <time_frame>5 months</time_frame>
    <description>Bone density will be measured by limited view CBCT radiography pre- and post-operatively.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Bone Quality</measure>
    <time_frame>5.5 months</time_frame>
    <description>Bone quality will be measured using histomorphometric analysis.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Alveolar Bone Resorption</condition>
  <condition>Sequela</condition>
  <condition>Tooth Extrusion</condition>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Control group in this study will comprise of 10 subjects and will receive Bio-Oss xenograft bone material.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Test Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The test group in this study will comprise of 10 subjects and will receive Shefabone synthetic bone substitute.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Shefabone</intervention_name>
    <description>Silica-calcium phosphate composite.</description>
    <arm_group_label>Test Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Bio-Oss</intervention_name>
    <description>Xenograft Bone substitute. Bone from animals.</description>
    <arm_group_label>Control Group</arm_group_label>
    <other_name>Bio-Oss by Geistlich</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  20 to 75 years of age&#xD;
&#xD;
          -  at least one maxillary edentulous posterior site requiring maxillary sinus grafting&#xD;
             and replacement with a dental implant.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  current smokers/tobacco users&#xD;
&#xD;
          -  are pregnant&#xD;
&#xD;
          -  have active periodontal disease&#xD;
&#xD;
          -  have uncontrolled diabetes&#xD;
&#xD;
          -  have any autoimmune disease&#xD;
&#xD;
          -  have kidney disease&#xD;
&#xD;
          -  have liver disease&#xD;
&#xD;
          -  are receiving radiation or chemotherapy&#xD;
&#xD;
          -  have any type of radiographic periapical pathology such as a periapical abscess.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rachad Kudsi, BDS</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Kentucky</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rachad Kudsi, BDS</last_name>
    <phone>3522161734</phone>
    <email>rku238@uky.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Kentucky</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40536</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sherry Hacker</last_name>
      <phone>859-353-2955</phone>
      <email>sherry.hacker@uky.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 11, 2020</study_first_submitted>
  <study_first_submitted_qc>June 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 16, 2020</study_first_posted>
  <last_update_submitted>June 24, 2021</last_update_submitted>
  <last_update_submitted_qc>June 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Kentucky</investigator_affiliation>
    <investigator_full_name>Rachad Kudsi</investigator_full_name>
    <investigator_title>Resident, Periodontology</investigator_title>
  </responsible_party>
  <keyword>Sinus pneumatization</keyword>
  <keyword>Socket preservation</keyword>
  <keyword>Sinus augmentation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bone Resorption</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Beneficial information for further research around the topic and/or information that may aid/benefit subjects or dentists in treatment may be shared.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

